ArticleTherapeutic advances in respiratory disease
Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective study.
Article in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 22 citations in OpenAlex.
- Host, Pathogen, and Pulmonary Anatomy in Pneumonia: An Integrated Imaging and Clinical Perspective.Diagnostics (Basel, Switzerland) · 2026Review
- Prevalence and Types of Gross Lung Lesions in Cattle Slaughtered at the Gondar ELFORA Abattoir: A Cross-Sectional Study.Veterinary medicine international · 2026Article
- Prognostic factors of lung abscess: a single-center retrospective cohort study.BMC pulmonary medicine · 2025Article
- A Pulmonary Abscess Caused by Porphyromonas gingivalis Infection: A Case Report and Literature Review.The clinical respiratory journal · 2025Review
- Heterogeneity in clinical patterns of adult lung abscess patients: an 8-year retrospective study in a tertiary hospital.BMC pulmonary medicine · 2025Article
- Effects of Prolonged Antibiotic Therapy in Lung Abscesses-Analysis of Case Series.Case reports in pulmonology · 2025Article
- Metagenomic Next-Generation Sequencing RevealsInfection and drug resistance · 2025Article
- Silent Invader: A Rare Case of Enterobacter aerogenes Empyema in a Hospice Patient With Complex Comorbidities.Cureus · 2024Article
- Clinical characteristics of apical segment lung abscess: a 10-year retrospective study.Journal of thoracic disease · 2024Article
- Article
- Article
- Prevalence and Phylogenetic Analysis ofArchives of Razi Institute · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPyogenic lung abscesses are rare and poorly described infections. This study aimed to describe their prognostic factors.
methodsWe retrospectively included all patients hospitalized between 1 January 1998 and 1 June 2018, with an International Classification of Diseases, version 10 (IDC-10) diagnosis of pyogenic lung abscess, from the Diamm based medical records (Micro6, Nancy, France). Parasitic, fungal, or mycobacterial lung abscesses were excluded.
resultsA total of 64 patients were included. Abscesses were associated with immunosuppression in 28 patients, including HIV infection and immunosuppressive therapy for eight and 12 patients, respectively. Bacterial identification was obtained for 36 patients. Nine patients (14%) developed lung abscesses after hematogenous dissemination. They differed from bronchogenic abscesses by their younger age (
conclusionA duration of antibiotic treatment of less than 6 weeks and bronchogenic presentation were globally associated with poor outcome of pyogenic lung abscesses. These data should be considered when proposing guidelines for the care of pyogenic lung abscesses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.